Home » Cosmetic Surgery Articles » Newly-Approved Facial Injectable Available at The Bougainvillea Clinique
Newly-Approved Facial Injectable Available at The Bougainvillea Clinique
Jeffrey M. Hartog, MD, is now offering Sculptra Aesthetic
WINTER PARK, FL, August 26, 2009 /Cosmetic Surgery PR News/ -- Jeffrey M. Hartog, MD, is now offering Sculptra Aesthetic (injectable poly-L-lactic acid), a cosmetic facial injectable that works gradually, resulting in a more youthful looking appearance that can last up to two years. Sculptra Aesthetic is approved by the U.S. Food and Drug Administration (FDA) as a treatment indicated for the correction of shallow to deep nasolabial fold (smile lines) contour deficiencies and other facial wrinkles which are treated with the appropriate injection technique in healthy people.
"I am very excited to offer Sculptra Aesthetic to patients who want to achieve natural-looking results from a cosmetic injectable that is long-lasting", said Dr. Jeffrey Hartog. "Sculptra Aesthetic works gradually to achieve results over time, so no one will notice you had work done."
Wrinkles and folds associated with aging become apparent, primarily through the breakdown of collagen. Sculptra Aesthetic helps the body replace lost collagen to provide a more youthful looking appearance.
A treatment regimen of Sculptra Aesthetic, an average of three injection sessions over a few months, has been shown to help correct facial lines and wrinkles by replacing lost collagen over time to provide noticeable results that can last up to two years. Sculptra Aesthetic is made from poly-L-lactic acid, which has been safely used for the past 25 years in resorbable stitches. It is biocompatible (a material that does not harm the body) and biodegradable (able to be broken down by the body). Injectable poly-L-lactic acid has also been widely used in Europe for close to a decade for cosmetic treatment.
In a pivotal trial with Sculptra Aesthetic, swelling and tenderness were the most common adverse events reported (81%).
Results from a recent study conducted for the American Society for Dermatologic Surgery (ASDS) and sanofi-aventis U.S. showed that both injectable users and women considering a medical anti-aging treatment prefer gradual results that last two years (75 percent) as opposed to immediate results that last one year (25 percent).
For more information, contact Liz at Dr. Jeffrey Hartog's office at (407) 678-3116 or visit www.lookandfeelbetter.com.
Important Safety Information:
You should not use Sculptra Aesthetic if you are allergic to any ingredient of the product or have a history of keloid formation or hypertrophic scarring. Sculptra Aesthetic should not be injected while you have an active skin infection or inflammation in the treatment area and should not be injected into the red area of the lip. Use in the skin near the eyes is not recommended.
Side effects of Sculptra Aesthetic may include injection site discomfort, redness, bruising, bleeding, itching and swelling. Other side effects may include small lumps under the skin that are sometimes noticeable when pressing on the treated area. Larger lumps, some with delayed onset with or without inflammation or skin discoloration, have also been reported. In a key clinical study the numbers of small and larger lumps were low and most resolved without treatment.
For complete prescribing information, please visit www.SculptraAesthetic.com.
Sculptra Aesthetic is a product of Dermik Laboratories, a business of sanofi-aventis U.S. LLC.
MEDIA CONTACT: Renee Taylor or Liz Montoya at (407) 678-3116
MEDIA CONTACT: Renee Taylor or Liz Montoya at (407) 678-3116
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com |
|
|
Press Release Contact Information:
Sara Goldstein
ePR Source
submission staff
17301 W. Colfax Ave Suite 275
Golden, CO
USA 80401
Voice: 13033849710
|
|
|
|
|
| COSMETIC SURGERY ARCHIVE SEARCH |
|
|
| |
| SUBMIT COSMETIC SURGERY NEWS |
|
|
| |
|
|
Advertise With Us |
About Us |
Contact Us